full-coral-evergreen.png
Kernal Biologics Presenting Results at the 9th Annual mRNA Health Conference
November 09, 2021 02:00 ET | Kernal Biologics, Inc.
CAMBRIDGE, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Kernal Biologics, Inc. (Kernal Bio) — an early-development-stage mRNA-technology company developing cancer therapeutics designed to improve...
kernalBioLogo.JPG
Kernal Biologics Enters Development Phase Reaching Critical Milestones for its First mRNA-Based Cancer-Therapeutic Product
July 22, 2021 08:00 ET | Kernal Biologics, Inc.
CAMBRIDGE, Mass., July 22, 2021 (GLOBE NEWSWIRE) -- Kernal Biologics, Inc. (Kernal Bio) — an early-development-stage mRNA-technology company developing cancer therapeutics designed to improve...
BioAffinity.jpg
bioAffinity Technologies Joins National Lung Cancer Roundtable
October 11, 2019 11:00 ET | bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, Oct. 11, 2019 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced that it has been accepted as a member of the American Cancer...
cfn_tweakedspacing.jpg
CFN Media's Exclusive Interview with Pascal Biosciences
November 08, 2018 08:30 ET | CFN Media
SEATTLE, Nov. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry,...
BioAffinity.jpg
bioAffinity Technologies Welcomes Peter S. Knight to Board of Directors
May 14, 2018 10:00 ET | bioAffinity Technologies, Inc.
SAN ANTONIO, May 14, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biomedical company advancing breakthrough cancer diagnostics and therapeutics, is pleased to welcome Peter S....
Onconova Therapeutics, Inc. to Present at PIONEERS 2017 Presented by Joseph Gunnar & Co., LLC
April 26, 2017 08:30 ET | Onconova Therapeutics
NEWTOWN, Pa., April 26, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical stage biopharmaceutical company focused on discovering and developing novel products to...
BioAffinity.jpg
bioAffinity Technologies Appoints New Senior VP for Research & Development of Therapeutics
July 07, 2016 08:00 ET | bioAffinity Technologies, Inc.
SAN ANTONIO, July 07, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies today announced that William Bauta, Ph.D., will join the company in September 2016 as Senior Vice President for Research and...